Search research articles
Contact Us
Filters
Showing results (61-70 of 122) with videos related to
Page
of 13
Sort By:
Gut and Liver
|
March 28, 2014
The risk factors and quality of life in patients with overlapping functional dyspepsia or peptic ulcer disease with gastroesophageal reflux disease
Shou-Wu Lee, Teng-Yu Lee, Han-Chung Lien, et al.
Journal of Clinical Medicine
|
August 26, 2022
The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma
Shou-Wu Lee, Sheng-Shun Yang, Han-Chung Lien, et al.
International Journal of Surgery (London, England)
|
July 17, 2024
Liver resection had better disease-free survival rates compared with radiofrequency ablation in hepatocellular carcinoma: a meta-analysis based on randomized clinical trials
Yee-Hui Yeo, Yi-No Kang, Chiehfeng Chen, et al.
Medicine
|
September 15, 2017
Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial
Teng-Yu Lee, Chen-Chun Lin, Chiung-Yu Chen, et al.
Plos One
|
December 1, 2017
Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
Yao-Kuang Huang, Chieh-Ling Yen, Sz-Iuan Shiu, et al.
Gut
|
September 10, 2020
Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor
Chun-Ying Wu, Hsiu J Ho, Chen-Yi Wu, et al.
Scientific Reports
|
February 26, 2024
Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes
Yu-Cheng Cheng, Teng-Yu Lee, Yu-Hsuan Li, et al.
Cancer Medicine
|
May 16, 2026
A Real-World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First-Line Lenvatinib
Shou-Wu Lee, Yi-Jie Huang, Hsin-Ju Tsai, et al.
Plos One
|
June 14, 2014
Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma
Chen-Shiou Wu, Teng-Yu Lee, Ruey-Hwang Chou, et al.
World Journal of Gastroenterology
|
October 16, 2012
Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis
Yi-Jun Liao, Chun-Ying Wu, Shou-Wu Lee, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 122) with videos related to
Sort By:
Page
of 13
Gut and Liver
|
March 28, 2014
The risk factors and quality of life in patients with overlapping functional dyspepsia or peptic ulcer disease with gastroesophageal reflux disease
Shou-Wu Lee, Teng-Yu Lee, Han-Chung Lien, et al.
Journal of Clinical Medicine
|
August 26, 2022
The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma
Shou-Wu Lee, Sheng-Shun Yang, Han-Chung Lien, et al.
International Journal of Surgery (London, England)
|
July 17, 2024
Liver resection had better disease-free survival rates compared with radiofrequency ablation in hepatocellular carcinoma: a meta-analysis based on randomized clinical trials
Yee-Hui Yeo, Yi-No Kang, Chiehfeng Chen, et al.
Medicine
|
September 15, 2017
Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial
Teng-Yu Lee, Chen-Chun Lin, Chiung-Yu Chen, et al.
Plos One
|
December 1, 2017
Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma
Yao-Kuang Huang, Chieh-Ling Yen, Sz-Iuan Shiu, et al.
Gut
|
September 10, 2020
Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor
Chun-Ying Wu, Hsiu J Ho, Chen-Yi Wu, et al.
Scientific Reports
|
February 26, 2024
Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes
Yu-Cheng Cheng, Teng-Yu Lee, Yu-Hsuan Li, et al.
Cancer Medicine
|
May 16, 2026
A Real-World Experience of Prognostic Factors of Survival Outcomes in a Taiwanese Population With Unresectable Hepatocellular Carcinoma Treated With First-Line Lenvatinib
Shou-Wu Lee, Yi-Jie Huang, Hsin-Ju Tsai, et al.
Plos One
|
June 14, 2014
Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma
Chen-Shiou Wu, Teng-Yu Lee, Ruey-Hwang Chou, et al.
World Journal of Gastroenterology
|
October 16, 2012
Adenosine deaminase activity in tuberculous peritonitis among patients with underlying liver cirrhosis
Yi-Jun Liao, Chun-Ying Wu, Shou-Wu Lee, et al.
Page
of 13